Event Type
Disclosure
Voluntary
Variant
8-K
Other Events. On January 12, 2026, Clene Inc. issued a press release announcing additional CNM-Au8 ® biomarker data supporting a potential new drug application
Financial Statements and Exhibits. (d) Exhibits Exhibit Number Exhibit Description 99.1 Press release, dated January 12, 2026, announcing additional CNM-Au8 bio